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Abstract
Background and Aims—The exploration and resolution of ambivalence play an essential role 
in motivational interviewing (MI) theory. However, most adolescent MI studies have not examined 
ambivalence as a contributor to behaviour change. This paper reviewed research findings on the 
role of ambivalence in the adolescent change process.
Methods and results—We undertook a narrative review of the published empirical and 
theoretical literature on ambivalence and mechanisms of change in MI for adolescents and found 
that current MI evaluations appear not to have access to reliable and valid measures of 
ambivalence in adolescence or neuroimaging methods to evaluate the mechanisms of treatment 
response.
Conclusions—Improved instrumentation is needed to assess adolescents’ ambivalence in 
clinical and research settings. Innovative methodology, including neuroimaging, may help identify 
factors mediating relationships between adolescents’ ambivalence and treatment response.
Keywords
motivational interviewing; adolescents; ambivalence; substance use; developmental; measurement; 
innovative approaches; neuroimaging; brain
INTRODUCTION
Currently, there is great controversy regarding how motivational interviewing (MI) [1] 
generates positive behavior change [2,3]. Critically, most large-scale, multi-site addiction 
treatment research has been conducted with adults (e.g., COMBINE; MATCH; UKATT) [4–
Correspondence to: Sarah W. Feldstein Ewing, Oregon Health & Science University, Department of Child & Adolescent Psychiatry, 
3314 SW US Veteran’s Hospital Rd. M/C DC7P Portland, OR 97239 USA. feldstei@ohsu.edu. 
Declarations of interests
None.
Clinical trial registration details
Not applicable.
HHS Public Access
Author manuscript
Addiction. Author manuscript; available in PMC 2016 November 01.
Published in final edited form as:
Addiction. 2016 November ; 111(11): 1900–1907. doi:10.1111/add.13286.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
6]. Despite the paucity of data on treatment mechanisms for adolescents, MI continues to be 
one of the strongest available evidence-based treatments for youth (SAMHSA; http://
www.nrepp.samhsa.gov/). Yet, meta-analyses examining the efficacy of MI for substance 
use disorders (SUDs) indicate that MI’s effect sizes are less robust for adolescents (mean d = 
0.17) [7] than adults (mean d = 0.77) [8]. This has direct implications for provision of care, 
particularly with high-need and underserved youth [9]. Clinicians need practical guidance 
regarding how to make MI more effective for adolescents. Unfortunately, MI studies are 
much clearer regarding what therapists should not do rather than what they should [10]. 
Resolution of ambivalence plays an essential role in MI [1]. Despite the burgeoning field on 
this mechanism of change in adults, ambivalence has been largely overlooked in adolescent 
clinical research [11]. Thus, we use this forum to explore the role of ambivalence in the 
adolescent change process.
AMBIVALENCE IN MOTIVATIONAL INTERVIEWING
Contrasting with other adolescent treatment models [12], ambivalence is at the heart of the 
clinical framework of MI [1], ‘a normal step on the road to change’ (p.157). Ambivalence 
represents a client’s experience of simultaneously feeling two ways about changing one’s 
behavior; for example, concurrently wanting to make a change while also feeling reticent to 
do so. Concretely, within clinical exchanges and MI theory, ambivalence is subsequently 
operationalized as client expressions in favor of change (change talk), which often co-occur 
with client expressions in favor of staying the same (sustain talk) [1] (e.g., ‘I know I should 
not drink, but I deserve to have fun!’).
Originally, MI training focused on ensuring clinicians’ acquisition of technical skills (e.g., 
the ‘how’ of MI, including use of open questions, complex reflections, affirmations). 
However, Miller and Rollnick observed that even among technically strong exchanges, to be 
effective, MI clinicians needed proficiency with an additional element - the ‘spirit’ of MI (p. 
14) [1]. MI spirit includes therapists’ degree of partnership, acceptance, compassion and 
evocation (p. 15) [1]. Thus, in MI practice, therapists’ must negotiate this delicate balance of 
relational and technical skills to address the key challenge in MI: to help clients ‘resolve’ 
ambivalence in the direction of behavior change [13]. Therapists can measure their degree of 
success helping their clients move through ambivalence by observing clients’ increased 
incidence of ‘change talk’ and decreased ‘sustain talk’ [1].
Predominantly examined with adults, most MI process research has focused on examining 
two predominant technical mechanisms of treatment response [3] [13]: the connection 
between therapist behaviors and client change talk, and the relationship between client 
change talk and post-treatment behavior change [14,15]. There are fewer studies evaluating 
the relationship between MI technical skills and behavior change among adolescents. In one 
study, Feldstein Ewing, Gaume, and colleagues [16] used process coding (via the 
Motivational Interviewing Treatment Integrity coding system; MITI) [17] to compare 
therapists’ technical skills with Hispanic versus non-Hispanic adolescents. The authors 
found that therapists employed significantly fewer MI skills with Hispanic youth (MI spirit; 
support of autonomy; complex reflections; evocation). Yet, this difference in therapist 
behaviors was only significantly negatively associated with Hispanic youths’ 3-month 
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alcohol-related problems outcomes. Both Hispanic and non-Hispanic youth showed 
equivalent treatment response across heavy drinking days, marijuana use days, and 
marijuana-related problems. Also using the MITI, McCambridge et al. [18] found that 
therapists’ level of MI spirit and complex reflections significantly predicted adolescents’ 3-
month cannabis cessation. In their regression model, neither adding therapist empathy nor 
any other additional therapist variable predicted participant outcomes or improved the fit of 
the model. In their study, therapists showed a high degree of variability in their MI skills; 
meaning, as with recent adult studies, therapists’ MI practice was not uniform across their 
clients [18,19].
Barnett and colleagues found that the type of therapist reflection impacted adolescents’ 
response [20]. For instance, therapists’ positive reflections (e.g., reflections favoring change) 
generated more adolescent change talk and less sustain talk, whereas therapists’ negative 
reflections (e.g., reflections supporting the status quo) resulted in youth generating more 
sustain talk and less change talk. Therapist reframing (e.g., positive restatement of client 
sustain talk; negative restatement of change talk), appeared to generate youth responses in 
the direction of the therapist’s statement. The authors suggest that therapist statements might 
operate as a ‘prime’ or ‘model’. These outcomes have been mirrored and linked to substance 
use reductions in group MI with at-risk adolescents [21].
These emergent findings are encouraging. However, clinicians are still missing crucial 
details on relational factors within the therapist-adolescent patient interactions. While often 
overlooked in the broader clinical literature as common, non-specific variables, in MI 
relational factors are defined as facets of therapists’ interpersonal exchanges including 
degree of empathy and therapeutic alliance; across addiction treatments including, but not 
limited to MI, relational factors play a significant role in client outcome [22,23]. Indeed, 
recent studies have begun to look closer at the impact of relational factors on behavior 
change in MI with adults [22,24–26].
Early studies of relational factors on adolescent treatment outcomes in MI have been mixed 
[27–29]. For instance, Feldstein Ewing and colleagues [29] did not find support for therapist 
empathy and alliance, as measured via standard working alliance inventories [30] and 
process coding (MITI) on treatment response with heavy drinking late adolescents [29]. In 
contrast, Baer and colleagues observed that therapist-rated estimates of youth engagement 
were associated with better MI treatment response in one of their evaluations, but not the 
other [27,28]. Ultimately, finer-grained, more precise tools are needed to deconstruct the 
extent to which the relationship between therapist technical and relational skills and 
ambivalence leads to adolescent behavior change [12].
AMBIVALENCE WITH ADOLESCENTS
One avenue where the adolescent MI relationship diverges from adult practice is around 
perceived negative consequences. For many adults, addiction is characterized by decades of 
substance use and serious, intractable symptoms, including loss of family and friends, 
disruption of employment, and severe negative health outcomes [31,32]. Although alcohol 
use is a strong contributor to accidents and injuries (the leading cause for morbidity and 
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mortality in this age group) [33], most substance-using adolescents do not perceive their 
substance use as problematic. Rather, many adolescents see no connection between their use 
and experienced problems with family, school, and/or friends [34–36]. More often, 
adolescents have strong positive experiences, associations, and expectations for substance 
use [37]. Further, as mass consumers of online and social media [38], adolescents post and 
view more positive, rather than negative, aspects of substance use, and have little exposure to 
real-world negative aspects of substance use [39]. Similarly, for many, substance use during 
adolescence is viewed as a normative, socially-indicated, time-limited behavior [40] that 
may even be advantageous in the short-term. For example, many youth report that substance 
use increases social currency, insulates against awkward or boring situations, increases 
confidence and facility in peer interactions, and provides symptom relief across sleep, 
depression, and attention issues [41].
Importantly, much of the MI knowledge base was generated with treatment-seeking adults 
who were acutely aware of their substance-related problems, and actively trying to reduce 
their use (e.g., COMBINE; MATCH; UKATT) [4–6]. In contrast, most youth in clinical 
research and treatment settings are non-treatment-seeking, ‘opportunistic’ clients [21,42], 
who arrive at the clinician’s office because addiction treatment is either an integrated 
component of their medical [42,43] or service system care [44,45], and/or because their 
parents, courts, or other external entities forced them to attend treatment [10].
Consequently, many adolescent clients receive addiction treatment despite their lack of 
interest in changing their substance use. Prominent MI theorists have contended that this 
may contribute to adolescents’ absence of ambivalence and related minimal expression of in-
session change talk during MI sessions. In the field of MI, it has been argued that it this very 
absence of ambivalence, which may occur for youth in their context of limited negative 
consequences, abundant positive experiences, and non-treatment seeking status [10], that 
operates against the likelihood of behavior change in MI [11]. Related, some argue that this 
may even contribute to the relatively lower effect sizes of MI observed with adolescents. 
However, we do not see this as a problem of ‘ambivalence’ [11]. Instead, we suggest that 
ambivalence may neither be a critical, nor necessary, ingredient in adolescents’ successful 
MI treatment response. In other words, in contrast to the position that ambivalence is 
requisite to MI success [11], what we find most provocative is that this position is not borne 
out by the adolescent meta-analytic data within substance use and other health behavior 
[(Cohen’s d = 0.17, 95% CI [.09, .25], n = 21) [7] 1; (Hedge’s g = .16; 95% CI [.05,f27], n = 
8) [46]; (Hedge’s g = 0.28; 95% CI [0.242, 0.323], n = 37)] [47]. Not as robust as the 
outcomes with adults, these data support that among non-treatment seeking youth who likely 
are not ambivalent about their use (and who have limited interest in changing) do show 
positive behavior change in MI, and across a range of behaviors. Consequently, the more apt 
question is how treating clinicians can best utilize MI relational and technical skills to 
maximize adolescent behavior change.
1Per study authors, Cohen’s d was calculated against the error MS and Hedge’s g was calculated using the square root of the mean 
square error in the denominator. Study authors report that while with large samples, Hedge’s g and Cohen’s d are often equivalent, 
Hedge’s g performs better with small samples.
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CAPTURING AMBIVALENCE WITH DECISIONAL BALANCE
Decisional balance is a classic clinical tool used to investigate ambivalence [48]. 
Conceptualized by Janis and Mann [49], decisional balance played a key role in the 
transtheoretical model of behavior change [50]. While some believe that use of decisional 
balance is sufficient to generate behavior change and/or confound decisional balance with 
MI [51], leaders of MI are increasingly discouraging clinicians from using decisional 
balance when the goal is behavior change [48].
In fact, this is an area of active discussion in the broader MI field. In the latest iteration of 
the MI text [1], Miller & Rollnick report a fairly open position on decisional balance, 
supporting its use to explore ‘pros and cons’ in a ‘neutral’ and ‘balanced way’ (p. 238). 
Concomitantly, Miller (48; personnel communication, July 13, 2015), contends that 
decisional balance is contraindicated in clinical exchanges with ambivalent individuals who 
have a low interest in changing, such as adolescents. Miller’s position is that decisional 
balance decreases motivation to change (operationalized by greater expression of sustain 
talk), which in turn, and maintains post-treatment sustain behavior [48]. Miller states that 
decisional balance is appropriate when a client has moved beyond ambivalence in the 
direction of change, at which point it can be used to address sustain talk, therapeutic discord, 
and/or concrete planning barriers toward change [48].
Although many have used decisional balance in MI with adolescents both in research trials 
[52–54] and direct patient care, we could find no targeted empirical examination isolating 
the impact of decisional balance on addiction treatment outcome for this age group. Thus, it 
might be the case that Miller’s position is supported, as sustain talk has been a robust 
predictor of poor post-treatment outcomes in adult [3] and the smaller body of adolescent 
studies [21,55]. However, we suggest that the MI therapeutic relationship is likely more 
nuanced with adolescents. For example, it is possible that for adolescents, decisional balance 
might help create ambivalence by giving a ‘head start’ when change talk is not yet present. 
This may be where relational component of effective MI interacts with adolescent intra-
individual factors, including ambivalence, to yield positive behavior change. Following adult 
studies [56], process research with younger samples might uncover that typically MI-
inconsistent therapist behaviors (e.g., confrontation) can lead to positive treatment outcomes 
when delivered with high empathy, therapeutic alliance and MI spirit. Empirical studies are 
needed to understand our metrics of ambivalence for adolescents, the efficacy and impact of 
our clinical approaches to enhance ambivalence (including whether or not decisional balance 
should be proscribed for adolescents), and how therapist relational factors interact with 
adolescents’ degree of ambivalence to facilitate or obstruct treatment gains.
RECONCILING CLINICAL RESEARCH AND PRACTICE: STEPS TOWARD 
INTEGRATION
The field of adolescent addiction is still very much in its infancy, with few large, multi-site 
studies examining this population (e.g., Cannabis Youth Trials) [57]. The field needs a series 
of studies that emphasize internal validity, establish the parametric boundaries of treatment 
(e.g., with what substances MI treatment is effective), and engage in dismantling projects to 
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determine the driving mechanisms of adolescent MI treatment response. Until then, we 
encourage clinicians and scientists to follow the guiding tenet of MI (1): to allow our clients 
to inform and guide our practice. We also offer these recommendations.
(1) Improve instrumentation for assessing adolescents’ ambivalence. In adolescent 
addiction treatment, it is common practice to adopt adult measures, and 
directly apply them with adolescents. We recommend caution with this 
approach; in some instances, adult measures operate well with youth. Yet, 
others suggest that the underlying processes of brain and behavioral response 
are quite different, and thus, direct translation might not be indicated [58,59].
We advocate for the development and empirical assessment of reliable and valid measures of 
ambivalence in adolescence, as operationalized from an MI viewpoint. This would allow us 
to move from speculation to data regarding the degree to which ambivalence is required in 
MI with adolescents. In the interim, one avenue to begin to deconstruct the degree of impact 
of ambivalence on adolescent behavior change is to work with process researchers to 
directly code for ambivalence statements. Some are already undertaking qualitative and 
linguistic analysis of transcripts around ambivalence themes [60]. This cutting-edge work 
will reveal critical advances in conceptualizations of ambivalence with adolescents, and 
guidance regarding how to manage it clinically.
(2) Utilize innovative methods to deconstruct these relationships. Another 
approach to determine what role ambivalence has in adolescent MI treatment 
response is through the unconventional application of neuroimaging. 
Neuroimaging allows fine-grained access to process variables that have been 
historically difficult to isolate and examine [61]. For example, Feldstein Ewing 
and colleagues have begun to illuminate critical developmental differences in 
adolescent neurocognitive processing of salient mechanisms of change (e.g., 
brain response during change talk in contemplation/self-reflection regions) 
[59]. This work has also highlighted the importance of relational factors, 
including genuine clinical MI relationships, in young brain response. For 
instance, young heavy drinkers showed greater brain activation to their own 
client language in the left inferior frontal gyrus/anterior insula and superior 
temporal gyri after working with a live MI clinician. In terms of youth brain 
response, there seems to be something particularly important about those 
statements originating in the context of therapy [62].
In the broader adult literature, in a subgroup comparison of adults with AUDs, LaBerre and 
colleagues [63] operationally defined ambivalence using self-report responses to Rollnick’s 
Readiness to Change questionnaire, completed upon treatment entry [64]. Individuals were 
categorized by their highest subscale scores, yielding two subgroups: ‘Pre-action’ (total n = 
10; n = 1 precontemplation, n = 9 contemplation) and ‘Action’ (n = 21). Compared with the 
Action group, the Preaction group showed significant differences in brain structure via MRI, 
including decreased gray matter volume across the right cerebellum (Crus I), bilateral 
fusiform gyri and frontal cortex (e.g., lateral orbitofrontal cortex, right ventromedial 
prefrontal cortex) and rostral cingulate areas (e.g., supplementary motor area, mid-cingulate 
gyrus; dorsolateral/ dorsomedial prefrontal cortex; caudate nucleus), brain areas that 
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underlie cognitive, social, and emotional functioning. When compared with the Action 
group, the Preaction group showed 13% smaller brain volume.
Paralleling these structural findings, with a sample of adult, treatment-seeking cigarette 
smokers who were planning to quit, Wilson and colleagues [65] evaluated ambivalence 
using a 6-item scale by Lipkus [66]. Total scores for ambivalence were generated by 
averaging responses across items. Wilson utilized an fMRI-based cigarette cue exposure 
paradigm to evaluate the link between ambivalence and cigarette cue response. This study 
found a negative correlation between ambivalence about smoking and functional activation 
in brain regions responsible for reward-processing, motivation, and attention (rostral anterior 
cingulate/medial frontal gyrus, caudate nucleus/thalamus, cuneus/lingual gyrus) during the 
cigarette cue.
Additional work in social and cognitive affective neuroscience has converged with these 
studies, indicating the role of key brain areas in error detection, conflict monitoring, reward 
processing, and introspection/contemplation in processing ambivalence, including the 
anterior cingulate cortex and the posterior cingulate cortex/precuneus [59,67–69]. Together, 
one perspective is that what we interpret as ‘ambivalence’ may in fact be a proxy of 
underlying differences in brain structure and function which contribute to the behavioral 
manifestation of lower interest in and ability to choose to and complete behavior change.
Given these findings, we recommend the use of neuroimaging as a vehicle to understand the 
mechanisms of treatment response, rather than as an indicator for precision medicine. A 
prominent topic in the US (www.whitehouse.gov/precision-medicine), precision medicine 
revolves around finding and utilizing treatment strategies that take individual variability into 
account [70]. In this respect, we are not advocating for all addiction clients to receive MRI/
fMRI prior to entry into treatment. Rather, it is our position that neuroimaging offers one 
tool to help us understand what ambivalence is in the adolescent brain, in order to give us a 
more sophisticated and sensitive measure of what the correlates and consequences of 
ambivalence might be.
In terms of what brain mechanisms of change might be (e.g., enduring change processes, 
markers of change, individual differences in responsiveness to interventions), neural 
substrates activated in response to ambivalence may be an active ingredient and/or they may 
be epiphenomenal [23,71]. Similarly, it might be the case that ambivalence processes 
represent a marker of an underlying neurocognitive process, rather than an enduring process 
of change. Using neuroimaging to examine these questions will allow us to eventually get 
closer to understanding the interplay between basic biological and behavioral factors within 
the process of change for youth [72] by offering one foundational research step that is 
needed prior to providing guidance to clinicians.
(3) Explore other theoretical models of adolescent MI change processes. One 
theoretical framework that may be useful with adolescents is the ‘conflict 
resolution’ hypothesis [73]. This proposes that MI is effective because it raises 
a client’s awareness of the conflict between their current behavior and short- or 
long-term goals and values. In this framework, the MI therapist aims to help 
the client examine and discuss both the benefits and costs of their substance 
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use to identify and elicit ambivalence about substance use. This is the first step, 
prior to clinical efforts to resolving ambivalence in the direction of change. 
This framework has received preliminary empirical support among heavy 
drinking college students [74]. While anecdotally consonant with our 
adolescent MI clinical experiences, empirical studies are requisite to determine 
the fit of this clinical framework.
(4) Developmental considerations for clinical steps. Here we cautiously step away 
from the empirical evidence. Until we have robust metrics of ambivalence that 
are accessible for clinicians working with adolescents, we encourage MI 
clinicians not to be fearful of ambivalence – or its absence - with their 
adolescent clients. Rather, both are well within the norm in the MI process, and 
within youths’ own journey towards change. We also encourage clinical and 
research teams to look more closely to the empirically more elusive relational 
factors, particularly the role of highly skilled and experienced therapists in 
clinical interactions. For example, one promising candidate is high-level 
therapeutic skill, which may help access adolescents’ clinical content, 
including ambivalence. Critically, the metric for this therapeutic active 
ingredient is reflective listening, which can, and has been measured [22,23,75]. 
In line with recent neurocognitive work with adolescents [62], this therapeutic 
active ingredient may be critical in producing adolescents’ MI treatment 
response [16,27].
LIMITATIONS AND CONCLUSIONS
It is our goal to administer the most powerful treatment agents, to give our adolescent clients 
the best chance at behavior change [9]. However, due to the relative absence of empirical 
studies on ambivalence with adolescents, we are still operating without sufficient data to 
implement the most effective interventions. While we have reviewed current data and theory 
in the adolescent MI change process, and suggested areas in need of further exploration, it is 
important to note that the relatively shorter substance use histories of adolescents also reflect 
a natural artifact of time. A critical direction for future work in this area must address the 
perceived importance of negative consequences and how that relates to readiness to change 
and treatment outcomes [76,77].
Together, the reviewed elements support that adolescents are not ‘little adults.’ Instead, MI 
practice needs to be articulated so that it addresses the treatment needs of adolescents to 
generate positive behavior change. It is our position that MI is a promising treatment for 
adolescents, but ambivalence may not be the central tenet underlying its success. We must 
make an effort to determine how and why MI works for this age group, in order to generate a 
treatment approach that is maximally effective. Concretely, conceptualizations and 
investigations of MI’s mechanisms of change will need to be updated accordingly.
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